Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
1.560
-0.070 (-4.29%)
At close: Jul 11, 2025, 4:00 PM
1.609
+0.049 (3.12%)
After-hours: Jul 11, 2025, 7:56 PM EDT
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $17.43 million as of July 11, 2025. Its market cap has decreased by -85.61% in one year.
Market Cap
17.43M
Enterprise Value
18.34M
1-Year Change
-85.61%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $17.43M, a decrease of -43.22%. That is a compound annual growth rate of -6.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 16.10M | -47.90% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 705.85B |
| Johnson & Johnson | 374.10B |
| AbbVie | 334.29B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 271.88B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 229.45B |
| AstraZeneca | 217.48B |